Pfizer Wins Lipitor Patent Challenge
On Friday, the U.S. District Court for the District of Delaware rejected a challenge by Ranbaxy, the Indian generic maker, against two Pfizer patents for Lipitor.
As a result of the decision, Pfizer will be entitled to a permanent injunction prohibiting Ranbaxy from obtaining approval for or marketing its generic version of Lipitor until 2011. The...
To view the full article, register now.